Original Data

Rev Diabet Stud, 2013, 10(1):58-67 DOI 10.1900/RDS.2013.10.58

Alpha-Lipoic Acid Improves Subclinical Left Ventricular Dysfunction in Asymptomatic Patients with Type 1 Diabetes

Sahar K. Hegazy1, Osama A. Tolba2, Tarek M. Mostafa1, Manal A. Eid3, Dalia R. El-Afify1

1Department of Clinical Pharmacy, Faculty of Pharmacy, Tanta University, Egypt
2Department of Pediatrics, Faculty of Medicine, Tanta University, Egypt
3Department of Clinical Pathology, Faculty of Medicine, Tanta University, Egypt
Address correspondence to: Dalia R El-Afify, e-mail: daliaelafify@yahoo.com

Manuscript submitted February 9, 2013; resubmitted March 27, 2013; accepted April 15, 2013.

Keywords: type 1 diabetes, diabetic cardiomyopathy, alpha-lipoic acid, oxidative stress, apoptosis, fibrosis, echocardiography


BACKGROUND: Oxidative stress plays an important role in the development of diabetic cardiomyopathy. Alpha-lipoic acid (ALA) is a powerful antioxidant that may have a protective role in diabetic cardiac dysfunction. AIM: We investigated the possible beneficial effect of alpha-lipoic acid on diabetic left ventricular (LV) dysfunction in children and adolescents with asymptomatic type 1 diabetes (T1D). SUBJECTS AND METHODS: Thirty T1D patients (aged 10-14) were randomized to receive insulin treatment (n = 15) or insulin plus alpha-lipoic acid 300 mg twice daily (n = 15) for four months. Age and sex matched healthy controls (n = 15) were also included. Patients were evaluated with conventional 2-dimensional echocardiographic examination (2D), pulsed tissue Doppler (PTD), and 2-dimensional longitudinal strain echocardiography (2DS) before and after therapy. Glutathione, malondialdhyde (MDA), nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), Fas ligand (Fas-L), matrix metalloproteinase 2 (MMP-2), and troponin-I were determined and correlated to echocardiographic parameters. RESULTS: Diabetic patients had significantly lower levels of glutathione and significantly higher MDA, NO, TNF-alpha, Fas-L, MMP-2, and troponin-I levels than control subjects. The expression of transforming growth factor beta (TGF-beta) mRNA in peripheral blood mononuclear cells was also increased in diabetic patients. Significant correlations of mitral e'/a' ratio and left ventricular global peak systolic strain with glutathione, MDA, NO, TNF-alpha, and Fas-L were observed in diabetic patients. Alpha-lipoic acid significantly increased glutathione level and significantly decreased MDA, NO, TNF-alpha, Fas-L, MMP-2, troponin-I levels, and TGF-beta gene expression. Moreover, alpha-lipoic acid significantly increased mitral e'/a' ratio and left ventricular global peak systolic strain in diabetic patients. CONCLUSION: These findings suggest that alpha-lipoic acid may have a role in preventing the development of diabetic cardiomyopathy in type 1 diabetes.

Fulltext: HTML , PDF (255KB)

This article has been cited by other articles:

The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: a systematic review and meta-analysis

Qiao YC, Chen YL, Pan YH, Tian F, Xu Y, Zhang XX, Zhao HL

Plos One 2017. 12(4):e0176157

Evaluation of Cardiac Functions in Children and Adolescents with Type 1 Diabetes

Abd-El Aziz FM, Abdelghaffar S, Hussien EM, Fattouh AM

J Cardiovasc Ultrasound 2017. 25(1):12-19

Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases

Bulaj G, Ahern MM, Kuhn A, Judkins ZS, Bowen RC, Chen Y

Curr Clin Pharmacol 2016. 11(2):128-145

Alpha-lipoic acid attenuates cardiac hypertrophy via inhibition of C/EBPβ activation

Zou J, Gan X, Zhou H, Chen X, Guo Y, Chen J, Yang X, Lei J

Mol Cell Endocrinol 2015. 399:321-329

Evaluation of Short Term Effect of Atorvastatin on Myocardial Performance and Its Pleiotropic Effects on Ischemic Heart Failure

El-Sisi A, Hegazy SK, Ahmed MK, Hamouda MA

Br J Pharmaceut Res 2015. 6(5):343-357

Physiological effect and therapeutic application of alpha lipoic acid

Park S, Karunakaran U, Jeoung NH, Jeon JH, Lee IK

Curr Med Chem 2014. 21(32):3636-3645

Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials

Pagano G, Aiello Talamanca A, Castello G, Cordero MD, d'Ischia M, Gadaleta MN, Pallardo FV, Petrovic S, Tiano L, Zatterale A

Int J Mol Sci 2014. 15(11):20169-20208

Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats

Xu J, Li H, Irwin MG, Xia ZY, Mao X, Lei S, Wong GT, Hung V, Cheung CW, Fang X, Clanachan AS, Xia Z.

Crit Care Med 2014. 42(8):e583-e594

Effect of the administration of alpha-lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes

Gebka A, Serkies-Minuth E, Raczynska D

Mediators Inflamm 2014. 2014:131538

Heart failure. Cardiovascular autonomic neuropathy in patients with diabetes mellitus

Bellmann B, Tschöpe C

Herz 2014. 39(3):306-311